000144649 001__ 144649
000144649 005__ 20220601113748.0
000144649 0247_ $$2doi$$a10.1201/b14584-25
000144649 037__ $$aDZNE-2020-00161
000144649 1001_ $$aDe Bartolo, Loredana$$b0$$eEditor
000144649 245__ $$aNeuroprotection and Neuroregeneration Strategies for Neurodegenerative Diseases
000144649 260__ $$bCRC Press$$c2013
000144649 29510 $$aBiomaterials for Stem Cell Therapy / De Bartolo, Loredana (Editor)   ;  : CRC Press, 2013,  ; ISBN: 978-1-4665-7639-1 ; doi:10.1201/b14584
000144649 300__ $$a495 - 537
000144649 3367_ $$2ORCID$$aBOOK_CHAPTER
000144649 3367_ $$07$$2EndNote$$aBook Section
000144649 3367_ $$2DRIVER$$abookPart
000144649 3367_ $$2BibTeX$$aINBOOK
000144649 3367_ $$2DataCite$$aOutput Types/Book chapter
000144649 3367_ $$0PUB:(DE-HGF)7$$2PUB:(DE-HGF)$$aContribution to a book$$bcontb$$mcontb$$s1654076064_17984
000144649 520__ $$aAcute and chronic neurodegenerative diseases of the central nervous system (CNS) are among the major challenges faced by neuroscientifi c research, by the pharmaceutical industry and by healthcare systems in most, if not all, industrialized countries. This situation is a consequence of our present inadequate understanding of the molecular and cellular mechanisms of neurodegeneration, and it has resulted in a lack of diagnostic resources and therapeutic options as well as in the need for long-term and costly nursing of patients. Many CNS diseases are correlated with age, and thus-following present-day world-wide demographic trends-they are becoming even more important. Consequently, better strategies to prevent, diagnose and/or treat diseases such as stroke and cerebral ischemia, Parkinson’s disease, German Center for Neurodegenerative Diseases (DZNE), AG Neurodegeneration and Intervention Strategies, c/o Universitätsklinikum, Leipziger Str. 44, D-39120 Magdeburg, Germany. Email: frank.striggow@dzne.de multiple sclerosis, Alzheimer’s disease and other forms of dementia are urgently needed. © 2013 by Taylor and Francis Group, LLC.
000144649 536__ $$0G:(DE-HGF)POF3-342$$a342 - Disease Mechanisms and Model Systems (POF3-342)$$cPOF3-342$$fPOF III$$x0
000144649 588__ $$aDataset connected to CrossRef Book
000144649 7001_ $$aBader, Augustinus$$b1$$eEditor
000144649 7001_ $$0P:(DE-2719)9000420$$aStriggow, Frank$$b2$$eCorresponding author$$udzne
000144649 773__ $$a10.1201/b14584-25
000144649 8564_ $$u10.1201/b14584-25
000144649 909CO $$ooai:pub.dzne.de:144649$$pVDB
000144649 9141_ $$y2013
000144649 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9000420$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b2$$kDZNE
000144649 9131_ $$0G:(DE-HGF)POF3-342$$1G:(DE-HGF)POF3-340$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lErkrankungen des Nervensystems$$vDisease Mechanisms and Model Systems$$x0
000144649 9201_ $$0I:(DE-2719)5000045$$kAG Striggow$$lNeurodegeneration and intervention strategies$$x0
000144649 980__ $$acontb
000144649 980__ $$aVDB
000144649 980__ $$aI:(DE-2719)5000045
000144649 980__ $$aUNRESTRICTED